Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

Primary care doctors need to monitor JAK and TYK-2 inhibitors carefully for skin conditions.

Immunofluorescence tomography is a cost-effective method for creating detailed 3-D images of tissues.

TAF can be identified by excessive skin thickening and clogged hair follicles, helping distinguish it from similar skin conditions.

Hinokitiol may help treat hair loss by reducing inflammation and promoting hair growth.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

Anti-angiogenic therapy can help treat cancer but may cause resistance and side effects, so alternative methods are being explored.

Early intervention and tailored management can reduce skin side effects from cancer treatments.

9-cis-retinoic acid showed some effectiveness in treating AIDS-related Kaposi sarcoma but had significant side effects at higher doses.

Lenvatinib and sorafenib are generally safe but need dose adjustments due to side effects.

Erlotinib can cause persistent excessive hair growth.

Photobiomodulation therapy helps manage cancer treatment side effects but needs more research for optimization.

The drug combination was safe and showed promise in treating advanced tumors.

New therapies and trials are needed for Merkel cell carcinoma, a tough skin cancer.

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

In 2024, the FDA approved 27 innovative small-molecule drugs, with many offering significant treatment improvements.

Using protein degradation to fight cancer drug resistance shows promise but needs more precise targeting and fewer side effects.

Early detection and multidisciplinary management of skin and mouth side effects from breast cancer treatments improve patient outcomes.

Targeting amphiregulin may improve treatment for fibrosis and cancer.

A young woman with kidney cancer experienced rare hair loss from a cancer drug and unusual cancer spread, suggesting early drug treatment might reduce spread and prolong survival.

Targeted radionuclide therapy shows promise for improving head and neck cancer treatment but needs more research.

Targeting amphiregulin may improve treatment for fibrotic diseases and cancer.

Certain drugs can change hair color, either lightening or darkening it.

Early diagnosis, innovative treatments, and considering systemic conditions are crucial in dermatological care.

Inhaling medicine may reduce side effects and improve treatment for a major lung cancer type.

Imatinib can cause hair loss due to lichen planopilaris.

Natural compounds may help treat advanced papillary thyroid cancer by targeting specific molecular pathways.

Dacomitinib can cause nail and skin issues, but these can be managed without stopping the drug.

Erlotinib can cause excessive eyelash growth.

High levels of ST14 and TMEFF1 proteins in ovarian cancer are linked to worse patient outcomes and may be a new treatment target.